Targeting better hypertension control with the usage of the ESH smartphone application
- 24 April 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (7) , 1162-1171
Abstract
Aims: Uncontrolled blood pressure is a main issue in the management of hypertensive patients, while mobile health (mHealth) offers a new perspective. This study aimed to investigate the efficacy of an mHealth app-based intervention, the European Society of Hypertension (ESH) CARE, in the management of uncontrolled hypertensive patients. Methods and results: This was a two-arm randomized, controlled trial conducted among 107 hypertensive patients, with uncontrolled office (≥140/90 mmHg) and 24-h ambulatory blood pressure (≥130/80 mmHg). After antihypertensive drug treatment initiation or intensification, patients were 1:1 randomized to application assisted strategy (AAS) group or usual care group, with scheduled visits at 1 and 3 months. In ASS group there was a virtual visit, while in usual care group there was an office visit. At 6 months, there was a final visit assessment with office and ambulatory blood pressure (BP) measurement. The mean age of the total population (n = 107) was 52.9 ± 9.6 years, 50.5% were women, without any significant differences in the baseline characteristics. At 6 months, 50% in the usual care group and 78.2% in the AAS group (P = 0.002) achieved both systolic and diastolic ambulatory BP targets (<130/80 mmHg). Regarding office BP, there was a reduction of 19.9 ± 9.1/12.4 ± 7.7 mmHg in the usual care group and 25.1 ± 6.4/16.3 ± 6.3 mmHg in the AAS group, while regarding ambulatory BP, there was a reduction of 6.6 ± 9.2/3.3 ± 6.2 mmHg and 10.9 ± 9.1/6.4 ± 5.5 mmHg, respectively. Conclusion: Follow-up of hypertensive patients with the ESH Care App is feasible and contributes to a significantly better office and out-of-office BP control after 6 months.Keywords
This publication has 34 references indexed in Scilit:
- Cost Savings and Improved Clinical Outcomes From a Mobile Health Cardiovascular Disease Self-Management ProgramValue in Health, 2025
- Digital health technologies and inequalities: A scoping review of potential impacts and policy recommendationsHealth Policy, 2024
- Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trialsThe Lancet Digital Health, 2023
- Clinic, Home, and Kiosk Blood Pressure Measurements for Diagnosing Hypertension: a Randomized Diagnostic StudyJournal of General Internal Medicine, 2022
- Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participantsThe Lancet, 2021
- Personalized Medicine and the Treatment of HypertensionCurrent Hypertension Reports, 2019
- Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trialThe Lancet, 2018
- Telemedicine and M-Health in Hypertension Management: Technologies, Applications and Clinical EvidenceHigh Blood Pressure & Cardiovascular Prevention, 2016
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet, 2016
- Lack of placebo effect on ambulatory blood pressureAmerican Journal of Hypertension, 1995